Precigen

PGEN • NASDAQ • Stock Fundamentals

Precigen is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Helen Sabzevari, with a market cap of $1.5B.

Market Cap$1.5B

Employees202.0

CEOHelen Sabzevari

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Precigen

Precigen (PGEN) has a market capitalization of $1.5B and trades on NASDAQ.

Precigen has approximately 202 employees.